Australia markets close in 1 hour 19 minutes

Longboard Pharmaceuticals, Inc. (LBPH)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
21.96+0.66 (+3.10%)
At close: 04:00PM EDT
21.96 0.00 (0.00%)
After hours: 04:01PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 853.38M
Enterprise value 805.35M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)20.85
Enterprise value/revenue N/A
Enterprise value/EBITDA -14.19

Trading information

Stock price history

Beta (5Y monthly) 1.25
52-week change 3165.22%
S&P500 52-week change 323.57%
52-week high 328.15
52-week low 33.60
50-day moving average 320.05
200-day moving average 312.11

Share statistics

Avg vol (3-month) 3526.79k
Avg vol (10-day) 3392.87k
Shares outstanding 533.61M
Implied shares outstanding 638.88M
Float 823.67M
% held by insiders 11.09%
% held by institutions 164.85%
Shares short (15 Apr 2024) 44.92M
Short ratio (15 Apr 2024) 410.3
Short % of float (15 Apr 2024) 417.12%
Short % of shares outstanding (15 Apr 2024) 412.66%
Shares short (prior month 15 Mar 2024) 43.74M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-58.48%
Return on equity (ttm)-106.30%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -56.75M
Net income avi to common (ttm)-54.42M
Diluted EPS (ttm)-2.39
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)48.5M
Total cash per share (mrq)1.35
Total debt (mrq)475k
Total debt/equity (mrq)1.16%
Current ratio (mrq)5.14
Book value per share (mrq)1.67

Cash flow statement

Operating cash flow (ttm)-50.87M
Levered free cash flow (ttm)-30.8M